What is Vertex Pharmaceuticals's changes in unrecognized tax benefits?

Vertex Pharmaceuticals (VRTX) reported changes in unrecognized tax benefits of $16.08M in Q4 2025.

What does changes in unrecognized tax benefits mean?

Changes in the reserves held for uncertain tax positions.

Vertex Pharmaceuticals Changes in unrecognized tax benefits remained flat by 0.0% to $16.08M in Q4 2025 compared to the prior quarter.

StatementIncome Statement

SectionOther

CategoryRisk

SignalContext dependent

VolatilityVolatile

First reportedQ1 2025

Last reportedQ4 2025Feb 13, 2026

Increases may indicate higher tax audit risk or aggressive tax positions; decreases may indicate resolution of past disputes.

The net change in reserves for unrecognized tax benefits, representing potential liabilities for uncertain tax positions...

Standard disclosure for tax contingencies under ASC 740.

Metric ID: other_income_tax_reconciliation_tax_contingencies

1 years

	FY'25
Value	$64.30M

What is Vertex Pharmaceuticals's changes in unrecognized tax benefits?: Vertex Pharmaceuticals (VRTX) reported changes in unrecognized tax benefits of $16.08M in Q4 2025.
What does changes in unrecognized tax benefits mean?: Changes in the reserves held for uncertain tax positions.